Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.

Pakistan journal of pharmaceutical sciences - 1 Oct 2010

Siddiqi Aisha, Khan Dilshad Ahmad, Khan Farooq Ahmed, Naveed Abdul Khaliq

Abstract excerpt

Variations of cytochrome-P450 enzyme system (CYP2CP) are associated with impaired metabolism of warfarin. The objective of our study was to estimate the frequency of genetic and allelic variants of CYP2C9 in Punjabi population of Pakistan and their effects on warfarin dose requirement. One hundred and twenty unrelated Pakistani subjects belong to Punjab province, were randomly included from the registry of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Gene Frequency

Share to Pakistan

Share to Polymorphism, Genetic

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Warfarin

Source

Identifiers

PMID: 20884456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.PMID 20884456Read ↗

Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.Semantic proximity Read ↗

Frequency of Common VKORC1 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population.Semantic proximity Read ↗

Genetic variations in drug-metabolizing enzyme CYP2C9 among major ethnic groups of Pakistani population.Semantic proximity Read ↗

Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.Semantic proximity Read ↗

Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population.Semantic proximity Read ↗

Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan.Semantic proximity Read ↗

Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population.Semantic proximity Read ↗

Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism.Semantic proximity Read ↗

Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose.Semantic proximity Read ↗

Variations in the frequencies of polymorphisms in the CYP2C9 gene in six major ethnicities of Pakistan.Semantic proximity Read ↗

Genetic and Nongenetic Determinants of Variable Warfarin Dose Requirements: A Report from North India.Semantic proximity Read ↗

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.